相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site
Shuo Chen et al.
CANCER CELL (2021)
Targeting a neoantigen derived from a common TP53 mutation
Emily Han-Chung Hsiue et al.
SCIENCE (2021)
p53's Extended Reach: The Mutant p53 Secretome
Evangelos Pavlakis et al.
BIOMOLECULES (2020)
MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemia
Pau Montesinos et al.
FUTURE ONCOLOGY (2020)
To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia
David A. Sallman
HAEMATOLOGICA (2020)
AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing
Ilyas Sahin et al.
CELL DEATH DISCOVERY (2020)
p53 β-hydroxybutyrylation attenuates p53 activity
Kun Liu et al.
CELL DEATH & DISEASE (2019)
COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms
Antje Lindemann et al.
CLINICAL CANCER RESEARCH (2019)
Cancer therapeutic targeting using mutant-p53-specific siRNAs
Ifeoma Ubby et al.
ONCOGENE (2019)
High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma
Katharina Bischof et al.
BMC CANCER (2018)
p53: emerging roles in stem cells, development and beyond
Abhinav K. Jain et al.
DEVELOPMENT (2018)
CHIP promotes autophagy-mediated degradation of aggregating mutant p53 in hypoxic conditions
Meenu Maan et al.
FEBS JOURNAL (2018)
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia
Luis A. Carvajal et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
Qiang Zhang et al.
CELL DEATH & DISEASE (2018)
A protein folding molecular imaging biosensor monitors the effects of drugs that restore mutant p53 structure and its downstream function in glioblastoma cells
Ramasamy Paulmurugan et al.
Oncotarget (2018)
Tumor suppressive role for kinases phosphorylating p53 in DNA damage-induced apoptosis
Satomi Yogosawa et al.
CANCER SCIENCE (2018)
Mechanisms of transcriptional regulation by p53
Kelly D. Sullivan et al.
CELL DEATH AND DIFFERENTIATION (2018)
Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM
Kurt Engeland
CELL DEATH AND DIFFERENTIATION (2018)
Thiosemicarbazones Functioning as Zinc Metallochaperones to Reactivate Mutant p53
Xin Yu et al.
MOLECULAR PHARMACOLOGY (2017)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
Liacine Bouaoun et al.
HUMAN MUTATION (2016)
Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks
Martin Fischer et al.
NUCLEIC ACIDS RESEARCH (2016)
Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells
Francesca Grespi et al.
CELL DEATH & DISEASE (2016)
COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
Kowthar Y. Salim et al.
ONCOTARGET (2016)
Oncogenic intra-p53 Family Member interactions in Human Cancers
Maria Ferraiuolo et al.
FRONTIERS IN ONCOLOGY (2016)
Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53
Shengliang Zhang et al.
CANCER RESEARCH (2015)
The p53 C Terminus Controls Site-Specific DNA Binding and Promotes Structural Changes within the Central DNA Binding Domain
Oleg Laptenko et al.
MOLECULAR CELL (2015)
Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
E. M. Alexandrova et al.
NATURE (2015)
Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4
Alla Polotskaia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mutant p53: One, no One, and One Hundred Thousand
Dawid Walerych et al.
FRONTIERS IN ONCOLOGY (2015)
Functional interplay between MDM2, p63/p73 and mutant p53
M. H. Stindt et al.
ONCOGENE (2015)
Synthetic Metallochaperone ZMC1 Rescues Mutant p53 Conformation by Transporting Zinc into Cells as an Ionophore
Adam R. Blanden et al.
MOLECULAR PHARMACOLOGY (2015)
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Patricia A. J. Muller et al.
CANCER CELL (2014)
Phosphorylation of p53 by TAF1 Inactivates p53-Dependent Transcription in the DNA Damage Response
Yong Wu et al.
MOLECULAR CELL (2014)
New insights into p53 functions through its target microRNAs
Jun-Ming Liao et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2014)
MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models
Christian Tovar et al.
CANCER RESEARCH (2013)
Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis
W. Hanel et al.
CELL DEATH AND DIFFERENTIATION (2013)
A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas
Andrew J. Wagner et al.
CLINICAL CANCER RESEARCH (2013)
Chaperone-mediated autophagy degrades mutant p53
Helin Vakifahmetoglu-Norberg et al.
GENES & DEVELOPMENT (2013)
Ratio disruption of the Δ133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma
Nichapavee Nutthasirikul et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells
Alessia Garufi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Discovery of RG7388, a Potent and Selective p53-MDM2 Inhibitor in Clinical Development
Qingjie Ding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Small molecule induced reactivation of mutant p53 in cancer cells
Xiangrui Liu et al.
NUCLEIC ACIDS RESEARCH (2013)
Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop
J. Zhang et al.
ONCOGENE (2013)
Targeting Mutant p53 by a SIRT1 Activator YK-3-237 Inhibits the Proliferation of Triple-Negative Breast Cancer Cells
Yong Weon Yi et al.
ONCOTARGET (2013)
The Human TLR Innate Immune Gene Family Is Differentially Influenced by DNA Stress and p53 Status in Cancer Cells
Maria Shatz et al.
CANCER RESEARCH (2012)
Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration
W. Andrew Yeudall et al.
CARCINOGENESIS (2012)
Dietary downregulation of mutant p53 levels via glucose restriction Mechanisms and implications for tumor therapy
Olga Catalina Rodriguez et al.
CELL CYCLE (2012)
MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function
S. Donzelli et al.
CELL DEATH AND DIFFERENTIATION (2012)
Mutant p53: one name, many proteins
William A. Freed-Pastor et al.
GENES & DEVELOPMENT (2012)
Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
Isabelle Ray-Coquard et al.
LANCET ONCOLOGY (2012)
Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer
Claudia Piovan et al.
MOLECULAR ONCOLOGY (2012)
Specific Recognition of p53 Tetramers by Peptides Derived from p53 Interacting Proteins
Ronen Gabizon et al.
PLOS ONE (2012)
MicroRNA-34a Modulates MDM4 Expression via a Target Site in the Open Reading Frame
Pooja Mandke et al.
PLOS ONE (2012)
MicroRNAs, wild-type and mutant p53 More questions than answers
Matthew Fletcher Jones et al.
RNA BIOLOGY (2012)
MicroRNAs in the p53 network: micromanagement of tumour suppression
Heiko Hermeking
NATURE REVIEWS CANCER (2012)
Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression
Colleen A. Brady et al.
CELL (2011)
SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
D. Li et al.
CELL DEATH AND DIFFERENTIATION (2011)
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition
Nam Hee Kim et al.
JOURNAL OF CELL BIOLOGY (2011)
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
Taewan Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells
Dun Li et al.
MOLECULAR CANCER RESEARCH (2011)
p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins
Levin Boehlig et al.
NUCLEIC ACIDS RESEARCH (2011)
P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism
S. Al-Bahlani et al.
ONCOGENE (2011)
Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells
Kazuhito Yoshikawa et al.
BIOMEDICAL RESEARCH-TOKYO (2010)
被撤回的出版物: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development (Retracted article. See vol. 40, pg. 1442, 2022)
Flavia Pichiorri et al.
CANCER CELL (2010)
p53-family proteins and their regulators: hubs and spokes in tumor suppression
L. Collavin et al.
CELL DEATH AND DIFFERENTIATION (2010)
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
Cliona Grant et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Identification and Characterization of the First Small Molecule Inhibitor of MDMX
Damon Reed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
p53 post-translational modification: deregulated in tumorigenesis
Chao Dai et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Clinical Outcomes and Correlates of TP53 Mutations and Cancer
Ana I. Robles et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway
N. V. Khromova et al.
CANCER LETTERS (2009)
Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding
Shwu-Yuan Wu et al.
EMBO JOURNAL (2009)
p53 Oligomerization Is Essential for Its C-terminal Lysine Acetylation
Yoko Itahana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway
Hyenjong Hong et al.
NATURE (2009)
Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2
D. P. Teufel et al.
ONCOGENE (2009)
p53 represses c-Myc through induction of the tumor suppressor miR-145
Mohit Sachdeva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structural Basis for p300 Taz2-p53 TAD1 Binding and Modulation by Phosphorylation
Hanqiao Feng et al.
STRUCTURE (2009)
p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair
Yu-Li Lin et al.
PLOS GENETICS (2009)
Influence of tetramerisation on site-specific post-translational modifications of p53
Lorna J. Warnock et al.
CANCER BIOLOGY & THERAPY (2008)
Coordinated Regulation of Cell Cycle Transcripts by p53-inducible microRNAs, miR-192 and miR-215
Sara A. Georges et al.
CANCER RESEARCH (2008)
Acetylation is indispensable for p53 activation
Yi Tang et al.
CELL (2008)
In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute
E. M. Michalak et al.
CELL DEATH AND DIFFERENTIATION (2008)
Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain
E. Christine Pietsch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Molecular basis of Pirh2-mediated p53 ubiquitylation
Yi Sheng et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway
J. E. Kravchenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
Frank M. Boeckler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
Jennifer J. Jordan et al.
PLOS GENETICS (2008)
IPI-504, a novel and soluble HSP-90 inhibitor, blocks the unfolded protein response in multiple myeloma cells
Jon Patterson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Ubiquitination and degradation of mutant p53
Natalia Lukashchuk et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
p53 is regulated by the lysine demethylase LSD1
Jing Huang et al.
NATURE (2007)
p63 and p73 in human cancer: defining the network
M. P. DeYoung et al.
ONCOGENE (2007)
p53-mediated activation of miRNA34 candidate tumor-suppressor genes
Guido T. Bommer et al.
CURRENT BIOLOGY (2007)
P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Hoseok Song et al.
NATURE CELL BIOLOGY (2007)
Integration of TGF-β and Ras/MAPK signaling through p53 phosphorylation
Michelangelo Cordenonsi et al.
SCIENCE (2007)
FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
ONCOLOGIST (2007)
Acetylation of the p53 DNA-binding domain regulates apoptosis induction
Stephen M. Sykes et al.
MOLECULAR CELL (2006)
Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis
Yi Tang et al.
MOLECULAR CELL (2006)
Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence
Lijin Feng et al.
CELL CYCLE (2006)
p63 protects the female germ line during meiotic arrest
Eun-Kyung Suh et al.
NATURE (2006)
Repression of p53 activity by Smyd2-mediated methylation
Jing Huang et al.
NATURE (2006)
Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways
Tianwei Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
Silvia Di Agostino et al.
CANCER CELL (2006)
A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network
F Toledo et al.
CANCER CELL (2006)
WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization
Y Tomita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The unique NH2-terminally deleted (ΔN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the ΔN variant of p63
ES Helton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tumor-derived p53 mutants induce NF-κB2 gene expression
MJ Scian et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63
F Bernassola et al.
ONCOGENE (2005)
p53 isoforms can regulate p53 transcriptional activity
JC Bourdon et al.
GENES & DEVELOPMENT (2005)
Blockage of NF-κB induces serine 15 phosphorylation of mutant p53 by JNK kinase in prostate cancer cells
LF Zerbini et al.
CELL CYCLE (2005)
Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs
VJN Bykov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity
BC Dash et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes
A Willis et al.
ONCOGENE (2004)
p73 induces apoptosis via PUMA transactivation and Bax mitochondrial translocation
G Melino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
JE Chipuk et al.
SCIENCE (2004)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Ser392 phosphorylation regulates the oncogenic function of mutant p53
DBS Yap et al.
CANCER RESEARCH (2004)
Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity
DP Xirodimas et al.
CELL (2004)
Living with or without cyclins and cyclin-dependent kinases
CJ Sherr et al.
GENES & DEVELOPMENT (2004)
被撤回的出版物: Transactivation of the EGR1 gene contributes to mutant p53 gain of function (Retracted article. See vol. 79, pg. 2085, 2019)
L Weisz et al.
CANCER RESEARCH (2004)
Facilitated search for specific genomic targets by p53 C-terminal basic DNA binding domain
YG Liu et al.
CANCER BIOLOGY & THERAPY (2004)
Post-translational modification of p53 in tumorigenesis
AM Bode et al.
NATURE REVIEWS CANCER (2004)
Prognostic significance of serine 392 phosphorylation in overexpressed p53 protein in human esophageal squamous cell carcinoma
M Matsumoto et al.
ONCOLOGY (2004)
Mono-versus polyubiquitination: Differential control of p53 fate by Mdm2
MY Li et al.
SCIENCE (2003)
Phosphorylation site interdependence of human p53 post-translational modifications in response to stress
S Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
MDM2-ARF complex regulates p53 sumoylation
LH Chen et al.
ONCOGENE (2003)
Improving cancer therapy by non-genotoxic activation of p53
S Lain et al.
EUROPEAN JOURNAL OF CANCER (2003)
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation
RP Leng et al.
CELL (2003)
Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain
JS Butler et al.
BIOCHEMISTRY (2003)
Phosphorylation and hsp90 binding mediate heat shock stabilization of p53
CG Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Acetylation of p53 inhibits its ubiquitination by Mdm2
MY Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity
SQ Jin et al.
ONCOGENE (2002)
Synthetic small inhibiting RNAs:: Efficient tools to inactivate oncogenic mutations and restore p53 pathways
LA Martinez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses
G Fontemaggi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
BID regulation by p53 contributes to chemosensitivity
JK Sax et al.
NATURE CELL BIOLOGY (2002)
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage
ER Flores et al.
NATURE (2002)
The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells
N Baptiste et al.
ONCOGENE (2002)
p53 mutant mice that display early ageing-associated phenotypes
SD Tyner et al.
NATURE (2002)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage
TR Shirangi et al.
FASEB JOURNAL (2002)
The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein
R Takimoto et al.
CANCER BIOLOGY & THERAPY (2002)
Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases
NA Barlev et al.
MOLECULAR CELL (2001)
Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization
YH Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1
J Sampath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment
JM Espinosa et al.
MOLECULAR CELL (2001)
Distinct pattern of p53 phosphorylation in human tumors
T Minamoto et al.
ONCOGENE (2001)
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
A Ito et al.
EMBO JOURNAL (2001)
A role for the polyproline domain of p53 in its regulation by Mdm2
M Berger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo
JR Jabbur et al.
ONCOGENE (2000)
Role of the heat shock response and molecular chaperones in oncogenesis and cell death
C Jolly et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Death and decoy receptors and p53-mediated apoptosis
MS Sheikh et al.
LEUKEMIA (2000)
p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours
A Yang et al.
NATURE (2000)
Identification of a sequence element from p53 that signals for Mdm2-targeted degradation
JJ Gu et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
